Table 3.

Multiple comparisons between the four types of monoclonal antibodies.

Characteristics	p-value Omalizumab vs Mepolizumab	p-value Omalizumab vs Reslizumab	p-value Omalizumab vs Benralizumab	p-value Mepolizumab vs Reslizumab	p-value Mepolizumab vs Benralizumab	p-value Reslizumab vs Benralizumab
Baseline exacerbations/year	0.011	0.251	0.019	0.185	0.493	0.138
Baseline hospital admissions/year	0.000	0.357	0.188	0.002	0.076	0.467
Level of eosinophils after 12 months	0.000	0.000	0.000	0.031	0.006	0.210

These comparisons were only performed for variables with a p-value ≤0.05. All possible pairwise comparisons (n = 6) were performed using the Mann–Whitney U test.